After demonstrating sensitivity to misfolded protein formation in immortalized cell lines during LEN or BTZ treatment individually or in combination, as a first step towards clinical translation, we applied MiROM to analyse protein misfolding in CD138+ purified primary myeloma cells from newly diagnosed myeloma patients (9 patients measured independently). Here, SDC1 is linked to plasma cell myeloma.